AC

Aisling Capital Portfolio holdings

AUM $45.3M
This Quarter Return
+33.14%
1 Year Return
-15.24%
3 Year Return
+386.13%
5 Year Return
+1,047.82%
10 Year Return
AUM
$485M
AUM Growth
+$485M
Cap. Flow
-$37.7M
Cap. Flow %
-7.76%
Top 10 Hldgs %
86.84%
Holding
22
New
Increased
3
Reduced
5
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
$105M 21.73% 4,028,920
ZLTQ
2
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$63.1M 13.01% 1,609,727 -500,000 -24% -$19.6M
CYNA
3
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
$45.1M 9.29% 1,121,381 +100,000 +10% +$4.02M
AIMT
4
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$44.9M 9.24% 2,990,000
VRAY
5
DELISTED
ViewRay, Inc.
VRAY
$33.8M 6.97% 7,480,887 +18,964 +0.3% +$85.7K
ARAV
6
DELISTED
Aravive, Inc. Common Stock
ARAV
$30.9M 6.37% 2,524,465 +244,897 +11% +$3M
CEMP
7
DELISTED
Cempra, Inc.
CEMP
$28.9M 5.95% 1,193,060
ADMA icon
8
ADMA Biologics
ADMA
$4.12B
$26.2M 5.39% 3,608,171
ESPR icon
9
Esperion Therapeutics
ESPR
$448M
$22.7M 4.67% 1,637,125
TTOO
10
DELISTED
T2 Biosystems, Inc
TTOO
$20.5M 4.22% 2,830,992
AGRX
11
DELISTED
Agile Therapeutics, Inc
AGRX
$15.9M 3.27% 2,275,455 -308,342 -12% -$2.15M
ASXC
12
DELISTED
Asensus Surgical, Inc.
ASXC
$14.1M 2.9% 8,335,819
CDTX icon
13
Cidara Therapeutics
CDTX
$1.66B
$11.7M 2.41% 1,021,148
SYRS
14
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$7.05M 1.45% 508,565 -400,000 -44% -$5.55M
PRTK
15
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$6.28M 1.29% 482,680
XENT
16
DELISTED
Intersect ENT, Inc
XENT
$3.94M 0.81% 248,498 -201,502 -45% -$3.19M
CMRX
17
DELISTED
Chimerix, Inc.
CMRX
$2.62M 0.54% 472,943
PTX
18
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$1.25M 0.26% 2,010,000
EVAR
19
DELISTED
Lombard Medical, Inc.
EVAR
$417K 0.09% 443,182 -443,181 -50% -$417K
CTLT
20
DELISTED
CATALENT, INC.
CTLT
-472,781 Closed -$10.9M
DERM
21
DELISTED
Dermira, Inc.
DERM
-102,593 Closed -$3M